Dashboard
Manage Tickers

QURE uniQure N.V.

Nasdaq uniqure.com


$ 29.99 $ -0.46 (-1.52 %)    

Friday, 14-Nov-2025 15:54:40 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 29.88
$ 29.00
$ 30.12 x 37
$ 30.19 x 134
$ 28.90 - $ 30.65
$ 5.50 - $ 71.50
1,829,606
na
1.86B
$ 1.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 07-29-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 11-05-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-01-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 02-27-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-02-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 10-25-2021 09-30-2021 10-Q
18 07-26-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 10-27-2020 09-30-2020 10-Q
22 07-30-2020 06-30-2020 10-Q
23 04-29-2020 03-31-2020 10-Q
24 03-02-2020 12-31-2019 10-K
25 10-28-2019 09-30-2019 10-Q
26 07-29-2019 06-30-2019 10-Q
27 04-29-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-08-2018 06-30-2018 10-Q
31 04-30-2018 03-31-2018 10-Q
32 03-14-2018 12-31-2017 10-K
33 11-01-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 03-15-2017 12-31-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
11/14/2025 17:35:28

wells-fargo-maintains-overweight-on-uniqure-lowers-price-target-to-60
Wells Fargo Maintains Overweight on uniQur...
11/12/2025 15:21:11

Wells Fargo analyst Yanan Zhu maintains uniQure (NASDAQ:QURE) with a Overweight and lowers the price target from $80 to $60.

chardan-capital-maintains-buy-on-uniqure-maintains-53-price-target
Chardan Capital Maintains Buy on uniQure, ...
11/11/2025 13:13:47

Chardan Capital analyst Daniil Gataulin maintains uniQure (NASDAQ:QURE) with a Buy and maintains $53 price target.

leerink-partners-maintains-outperform-on-uniqure-lowers-price-target-to-60
Leerink Partners Maintains Outperform on u...
11/10/2025 21:18:50

Leerink Partners analyst Joseph Schwartz maintains uniQure (NASDAQ:QURE) with a Outperform and lowers the price target from ...

correction-uniqure-q3-eps-138-misses-090-estimate-sales-3701m-miss-5243m-estimate
CORRECTION: UniQure Q3 EPS $(1.38) Misses ...
11/10/2025 14:45:26

uniQure (NASDAQ:QURE) reported quarterly losses of $(1.38) per share which missed the analyst consensus estimate of $(0.90) by ...

mondaycom-metsera-profrac-holding-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Monday.Com, Metsera, Profrac Holding And O...
11/10/2025 11:18:29

earnings-scheduled-for-november-10-2025
Earnings Scheduled For November 10, 2025
11/10/2025 11:12:02

a-glimpse-of-uniqures-earnings-potential
A Glimpse of uniQure's Earnings Potential
11/07/2025 17:05:12

biohaven-stock-hits-52-week-low-cuts-rd-spending-after-fda-rejection
Biohaven Stock Hits 52-Week Low, Cuts R&D ...
11/05/2025 17:53:02

Biohaven stock plunged after the FDA rejected Vyglxia for spinocerebellar ataxia, prompting major R&D cuts and a William Bl...

super-micro-computer-posts-downbeat-q1-results-joins-pinterest-axon-enterprise-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Super Micro Computer Posts Downbeat Q1 Res...
11/05/2025 13:45:15

why-teradata-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Teradata Shares Are Trading Higher By ...
11/05/2025 10:09:59

fdas-rigid-approach-adds-uncertainty-to-uniqures-accelerated-pathway-for-huntingtons-gene-therapy
FDA's Rigid Approach Adds Uncertainty To u...
11/04/2025 19:25:08

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval ...

goldman-sachs-maintains-neutral-on-uniqure-lowers-price-target-to-38
Goldman Sachs Maintains Neutral on uniQure...
11/04/2025 17:05:20

Goldman Sachs analyst Salveen Richter maintains uniQure (NASDAQ:QURE) with a Neutral and lowers the price target from $56 to...

rbc-capital-maintains-outperform-on-uniqure-lowers-price-target-to-45
RBC Capital Maintains Outperform on uniQur...
11/04/2025 16:51:06

RBC Capital analyst Luca Issi maintains uniQure (NASDAQ:QURE) with a Outperform and lowers the price target from $65 to $45.

insperity-posts-downbeat-q3-results-joins-iac-archer-daniels-midland-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Insperity Posts Downbeat Q3 Results, Joins...
11/04/2025 14:00:14

william-blair-downgrades-uniqure-to-market-perform
William Blair Downgrades uniQure to Market...
11/04/2025 12:18:12

William Blair analyst Sami Corwin downgrades uniQure (NASDAQ:QURE) from Outperform to Market Perform.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 12:05:48

hc-wainwright--co-maintains-buy-on-uniqure-lowers-price-target-to-70
HC Wainwright & Co. Maintains Buy on uniQu...
11/04/2025 11:52:06

HC Wainwright & Co. analyst Patrick R. Trucchio maintains uniQure (NASDAQ:QURE) with a Buy and lowers the price target f...

why-upwork-shares-are-trading-higher-by-over-22-here-are-20-stocks-moving-premarket
Why Upwork Shares Are Trading Higher By Ov...
11/04/2025 11:22:41

chardan-capital-maintains-buy-on-uniqure-lowers-price-target-to-53
Chardan Capital Maintains Buy on uniQure, ...
11/03/2025 21:32:33

Chardan Capital analyst Daniil Gataulin maintains uniQure (NASDAQ:QURE) with a Buy and lowers the price target from $76 to $53.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION